Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael J Parnham

Showing results (71-80 of 101) with videos related to

Pageof 11
Sort By:
Pharmacological Research|February 15, 2011
Macrolide antibiotics broadly and distinctively inhibit cytokine and chemokine production by COPD sputum cells in vitroNikola Marjanović, Martina Bosnar, Francesca Michielin, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 12, 2016
Optimizing novel implant formulations for the prolonged release of biopharmaceuticals using in vitro and in vivo imaging techniquesSusanne Beyer, Li Xie, Mike Schmidt, et al.
EMBO Molecular Medicine|October 2, 2014
R-flurbiprofen attenuates experimental autoimmune encephalomyelitis in miceKatja Schmitz, Natasja de Bruin, Philipp Bishay, et al.
International Journal of Molecular Sciences|January 3, 2017
R-Flurbiprofen Traps Prostaglandins within Cells by Inhibition of Multidrug Resistance-Associated Protein-4Ivonne Wobst, Lisa Ebert, Kerstin Birod, et al.
Environmental Research|September 27, 2020
Predicting the environmental emissions arising from conventional and nanotechnology-related pharmaceutical drug productsFabian Jung, Manuela Thurn, Katharina Krollik, et al.
Journal of Immunotoxicology|April 5, 2024
IL-2-mediated hepatotoxicity: knowledge gap identification based on the irAOP conceptLuise A Roser, Christina Sakellariou, Malin Lindstedt, et al.
Shock (Augusta, Ga.)|January 23, 2016
Pparγ Expression in T Cells as a Prognostic Marker of SepsisMarco Brenneis, Ramin Aghajaanpour, Tilo Knape, et al.
Nature Reviews. Drug Discovery|November 17, 2020
Improving target assessment in biomedical research: the GOT-IT recommendationsChristoph H Emmerich, Lorena Martinez Gamboa, Martine C J Hofmann, et al.
Pharmaceuticals (Basel, Switzerland)|September 23, 2022
In Vitro Safety, Off-Target and Bioavailability Profile of the Antiviral Compound SilvestrolSusanne Schiffmann, Sandra Gunne, Thomas Ulshöfer, et al.
Scientific Reports|May 7, 2020
In-vitro safety and off-target profile of the anti-parasitic arylmethylaminosteroid 1oLeonard Blum, Sheraz Gul, Thomas Ulshöfer, et al.
Pageof 11

Showing results (71-80 of 101) with videos related to

Sort By:
Pageof 11
Pharmacological Research|February 15, 2011
Macrolide antibiotics broadly and distinctively inhibit cytokine and chemokine production by COPD sputum cells in vitroNikola Marjanović, Martina Bosnar, Francesca Michielin, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 12, 2016
Optimizing novel implant formulations for the prolonged release of biopharmaceuticals using in vitro and in vivo imaging techniquesSusanne Beyer, Li Xie, Mike Schmidt, et al.
EMBO Molecular Medicine|October 2, 2014
R-flurbiprofen attenuates experimental autoimmune encephalomyelitis in miceKatja Schmitz, Natasja de Bruin, Philipp Bishay, et al.
International Journal of Molecular Sciences|January 3, 2017
R-Flurbiprofen Traps Prostaglandins within Cells by Inhibition of Multidrug Resistance-Associated Protein-4Ivonne Wobst, Lisa Ebert, Kerstin Birod, et al.
Environmental Research|September 27, 2020
Predicting the environmental emissions arising from conventional and nanotechnology-related pharmaceutical drug productsFabian Jung, Manuela Thurn, Katharina Krollik, et al.
Journal of Immunotoxicology|April 5, 2024
IL-2-mediated hepatotoxicity: knowledge gap identification based on the irAOP conceptLuise A Roser, Christina Sakellariou, Malin Lindstedt, et al.
Shock (Augusta, Ga.)|January 23, 2016
Pparγ Expression in T Cells as a Prognostic Marker of SepsisMarco Brenneis, Ramin Aghajaanpour, Tilo Knape, et al.
Nature Reviews. Drug Discovery|November 17, 2020
Improving target assessment in biomedical research: the GOT-IT recommendationsChristoph H Emmerich, Lorena Martinez Gamboa, Martine C J Hofmann, et al.
Pharmaceuticals (Basel, Switzerland)|September 23, 2022
In Vitro Safety, Off-Target and Bioavailability Profile of the Antiviral Compound SilvestrolSusanne Schiffmann, Sandra Gunne, Thomas Ulshöfer, et al.
Scientific Reports|May 7, 2020
In-vitro safety and off-target profile of the anti-parasitic arylmethylaminosteroid 1oLeonard Blum, Sheraz Gul, Thomas Ulshöfer, et al.
Pageof 11